Cargando…
Urinary Neuropilin-1: A Predictive Biomarker for Renal Outcome in Lupus Nephritis
At present, Lupus Nephritis (LN) is still awaiting a biomarker to better monitor disease activity, guide clinical treatment, and predict a patient’s long-term outcome. In the last decade, novel biomarkers have been identified to monitor the disease, but none have been incorporated into clinical prac...
Autores principales: | Torres-Salido, Maria Teresa, Sanchis, Mireia, Solé, Cristina, Moliné, Teresa, Vidal, Marta, Vidal, Xavier, Solà, Anna, Hotter, Georgina, Ordi-Ros, Josep, Cortés-Hernández, Josefina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769814/ https://www.ncbi.nlm.nih.gov/pubmed/31533337 http://dx.doi.org/10.3390/ijms20184601 |
Ejemplares similares
-
An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis
por: Solé, Cristina, et al.
Publicado: (2019) -
The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis
por: Garcia-Vives, Eloi, et al.
Publicado: (2020) -
MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis
por: Domingo, Sandra, et al.
Publicado: (2020) -
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
por: Cortés-Hernández, Josefina, et al.
Publicado: (2012) -
Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways
por: Domingo, Sandra, et al.
Publicado: (2021)